Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase

Medicine & Life Sciences

• GSK1904529A 100%
• IGF Type 1 Receptor 54%
• Protein-Tyrosine Kinases 39%
• Insulin Receptor 18%
• Neoplasms 10%
• Heterografts 9%
• Cell Line 9%
• Ewing's Sarcoma 6%
• Hematologic Neoplasms 5%
• Multiple Myeloma 5%
• Cell Cycle Checkpoints 5%
• Sarcoma 5%
• Nude Mice 5%
• Oral Administration 4%
• Prostate 4%
• Blood Glucose 4%
• Therapeutic Uses 4%
• Colon 4%
• Research Design 4%
• Cell Cycle 4%
• Phosphotransferases 4%
• Breast 4%
• Phosphorylation 3%
• Cell Proliferation 3%
• Glucose 3%
• Growth 2%
• Animals 2%
• In Vitro Techniques 2%
• Therapeutics 0%